Concurrent medications, particularly those associated with weight gain such as certain antidepressants or antipsychotics, may partially counteract weight loss effects
Obesity is a term that can feel subjective
Tirzepatide may offer the potential for greater weight loss compared to Ozempic due to its dual action on multiple hormonal pathways involved in appetite regulation and metabolism
Despite these extensive studies, several questions remain open, such as which DCX + cells contribute to post-lesional neurogenesis and which stroke-induced factors trigger the altered migration of neuroblasts into the infarct area
It gives Novo Nordisk an opportunity to remain competitive on efficacy while it continues developing next-generation therapies. Other drugs have already shown greater efficacy in prior studies, and the broader GLP-1 space is likely to see much more significant change as new molecules enter the market. Balazs called the higher dosage a major jump, noting that the incidences of stomach- and skin-related side effects at this higher dose are meaningful. This approval is for obesity management, not diabetes treatment, the expert emphasized
The records, spanning the period from 2022 through mid-2025, showed that more than 15,000 of the women had a prescription for GLP-1 medications, and more than 96,000 had no records of GLP-1 prescriptions